Loading clinical trials...

An Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia | Clinical Trials | Clareo Health

COMPLETED

An Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia

A Non-Interventional Prospective Cohort Study of Patients With Persistent Symptoms of Schizophrenia to Describe The Course and Burden of Illness

NCT01634542•Hoffmann-La Roche

View on ClinicalTrials.gov

Summary

This multicenter, prospective, non-interventional study will evaluate the prevalence and characteristics of patients with persistent symptoms of schizophrenia and the course of their illness over 24 months.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patients:
•Adult patients, \>/= 18 years of age
•Diagnosis of schizophrenia according to Diagnostic and Statistical Manual for Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR) or International Classification of Diseases, 10th revision (ICD-10)
•Caregivers:
•Age \>/= 18 years
•Family member or friend of the patient, who spends at least 4 hours a week with the patient

Exclusion Criteria

•Acute psychotic exacerbation in the 3 months prior to the baseline observation (e.g. hospitalization or increased psychiatric care in order to prevent hospitalization)
•Enrolled in an interventional study at the baseline observation

Locations (148)

Buenos Aires, Argentina

Caba, Argentina

La Plata, Argentina

Goiânia, Goiás, Brazil

Curitiba, Paraná, Brazil

São Paulo, São Paulo, Brazil

Medicine Hat, Alberta, Canada

Vancouver, British Columbia, Canada

Chatam, Ontario, Canada

Key Dates

Start Date

February 1, 2011

Primary Completion Date

December 1, 2014

Completion Date

December 1, 2014

Last Updated

November 2, 2016

Enrollment

1,433

ACTUAL participants

Conditions

Schizophrenia

Feasibility, Acceptability, and Preliminary Efficacy of Yoga-based Group Intervention for Outpatients With Schizophrenia Spectrum Disorders

NCT07455929

Psychotic DisordersSchizophrenia Spectrum Disorders

View study

RECRUITING

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

NCT06740383

Schizophrenia Spectrum and Other Psychotic DisordersSchizophrenia+5 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 2, 2016Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

An Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia

Inclusion Criteria

Exclusion Criteria

Feasibility, Acceptability, and Preliminary Efficacy of Yoga-based Group Intervention for Outpatients With Schizophrenia Spectrum Disorders

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With Schizophrenia

Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Disorders

Brain Stimulation to the Hippocampus in Schizophrenia

Develop a Novel Occupational Training Program for Schizophrenia Patients Based on Virtual Reality Techniques